StemRIM Inc. (4599) Dividends

Market cap
¥19.3B
P/E ratio
StemRim develops regenerative induction pharmaceuticals that activate patients' own stem cells to repair damaged tissues using peptide-based drugs like Ledasemdide.

Latest Dividend per Share Forecast

0.00JPY

If you buy 100 shares of StemRIM Inc., the expected annual dividend is 0 JPY.

Dividend Yield
-
Payout Ratio
-

Dividend Policy

<p>While we will consider distributing surplus funds in the future by taking into account our business performance and financial condition, our current policy is to prioritize securing funds for research and development activities that require substantial upfront investment, and therefore we will not pay dividends at this time. We plan to allocate retained earnings to research and development. Should we decide to distribute surplus funds, we intend to do so once per year at the fiscal year-end.</p>

Dividend per Share

Payout Ratio

Dividend Yield

Subscribe to premium to access
Dividend Yield.

Check pricing

Dividend History (Forecasts, Revisions, Actuals)

Fiscal YearTypeInterimYear-EndTotalPayout Ratio
FY2026Forecast(2025/09/10)000-
FY2025Actual(2025/09/10)000-
Forecast(2024/09/11)000-
FY2024Actual(2024/09/11)000-
Forecast(2023/09/13)000-
FY2023Actual(2023/09/13)000-
Forecast(2022/09/08)000-
FY2022Actual(2022/09/08)000-
Forecast(2021/09/09)000-
FY2021Actual(2021/09/09)000-
Forecast(2020/09/10)000-
FY2020Actual(2020/09/10)-00-
FY2019Actual(2020/09/10)000-
AI Chat